These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 18446029

  • 1. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases.
    Descamps V, Landry J, Francès C, Marinho E, Ratziu V, Chosidow O.
    Dermatology; 2008; 217(1):81-4. PubMed ID: 18446029
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ, Romagosa R, Vincek V.
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract] [Full Text] [Related]

  • 3. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
    Honsová E, Sticová E, Sperl J.
    Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
    [Abstract] [Full Text] [Related]

  • 4. Foreign body granulomatous reaction to silica, silicone, and hyaluronic acid in a patient with interferon-induced sarcoidosis.
    Novoa R, Barnadas MA, Torras X, Curell R, Alomar A.
    Actas Dermosifiliogr; 2013 Dec; 104(10):920-3. PubMed ID: 22995946
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C.
    Chiang CH, Lai FJ.
    J Formos Med Assoc; 2014 Dec; 113(12):981-2. PubMed ID: 25187070
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
    Hurst EA, Mauro T.
    Arch Dermatol; 2005 Jul; 141(7):865-8. PubMed ID: 16027302
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies.
    Fischer J, Metzler G, Schaller M.
    Arch Dermatol; 2007 Apr; 143(4):507-10. PubMed ID: 17438184
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM, Davis C, Olerud J.
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
    López V, Molina I, Monteagudo C, Jordá E.
    Int J Dermatol; 2011 Mar; 50(3):287-91. PubMed ID: 21342161
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
    Hoffmann RM, Jung MC, Motz R, Gössl C, Emslander HP, Zachoval R, Pape GR.
    J Hepatol; 1998 Jun; 28(6):1058-63. PubMed ID: 9672184
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.